DIH Holding US, Inc., Announces Strategic Partnership with B-Temia Inc. to Revolutionize the Rehabilitation Market
DIH Holding has announced a strategic partnership with B-Temia to revolutionize the rehabilitation market by integrating AI-based robotics and smart solutions. The collaboration will incorporate Keeogo Dermoskeleton into DIH's offerings, enabling concurrent therapies for patients in semi-acute and chronic phases. The partnership gives DIH exclusive rights to market Keeogo in Canada, the US, and Mexico, aiming to enhance its product range and industry leadership. DIH plans to validate these innovations in the US market first before global rollout. The partnership seeks to improve patient outcomes through advanced AI and Machine Learning technologies.
- Partnership with B-Temia to integrate AI-based robotics into rehabilitation solutions.
- Exclusive rights to market and sell Keeogo Dermoskeleton in Canada, the US, and Mexico.
- Expansion of DIH's product range, reinforcing its commitment to cutting-edge solutions.
- Initial validation and launch in the US market, with plans for global expansion.
- Potential risks associated with the integration of new technologies and their validation.
- Increased competition in AI-based rehabilitation market may pressure profit margins.
- Financial and operational risks tied to the exclusive marketing rights in new regions.
Insights
The partnership between DIH and B-Temia represents a significant advancement in the rehabilitation technology sector. By integrating AI and ML into rehabilitation robotics, this collaboration may result in a more intuitive user experience and improved patient outcomes. These technologies can facilitate real-time adjustments and personalized therapy plans, making rehabilitation more effective. Additionally, the inclusion of Keeogo Dermoskeleton™ into DIH's portfolio is noteworthy. This innovation has already garnered positive feedback for its assistance in mobility, thus enhancing DIH's product offerings. The exclusive rights to distribute in North America should also provide DIH with a competitive advantage in these markets. Investors should monitor the development and market acceptance of these integrated solutions, as successful implementation could significantly bolster DIH's market position.
This strategic partnership is likely to have a favorable impact on DIH's market presence. The integration of Keeogo Dermoskeleton™ expands DIH's product portfolio, offering advanced solutions to a broader customer base. This move could capture a larger market share in the rehabilitation sector by addressing a growing demand for AI-driven therapeutic solutions. The initial launch in the US market is a strategic step to gauge market reception and refine the product before a global rollout. Moreover, the collaboration reinforces DIH's commitment to innovation and maintaining its leadership in the rehabilitation technology industry. Investors should watch for updates on market penetration and customer feedback, as these will be critical indicators of the partnership's success and its potential to drive revenue growth.
NORWELL, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH”) (NASDAQ:DHAI), a leading global robotics and virtual reality (“VR”) technology provider in the rehabilitation and human performance industry, today announced a strategic partnership with B-Temia Inc. aimed at driving AI-based innovation and smart integral solutions in the rehabilitation market. Leveraging B-Temia's expertise in AI-based robotics development alongside DIH's smart integral solutions and broad robotic portfolios, this collaboration marks a significant step forward in enhancing the quality of life for individuals in need of functional rehabilitation and support.
Under this partnership, DIH and B-Temia will join forces to integrate state-of-the-art technologies into smart integral solutions for a transformative effect to further enrich DIH’s offerings and industry leadership. The integration of Keeogo™ Dermoskeleton™ into DIH's offerings will enable simultaneous con-current therapies that may benefit patients in both semi-acute and chronic phases effectively. The incorporation of Artificial Intelligence (AI) and Machine Learning (ML) will enhance these systems, leading to optimal performance and improved user experience. DIH plans to validate the integration concepts and launch in the US market initially prior to bringing the expanded integral solutions to customers and patients worldwide.
Keeogo, developed by B-Temia, has garnered widespread acclaim for its innovative design and effectiveness in assisting individuals with mobility challenges. Through this partnership, DIH will have exclusive rights to market and sell Keeogo in Canada, the US and Mexico. This partnership not only expands DIH's product range but also reinforces its commitment to providing cutting-edge solutions through clinical integration to customers across the regions.
“We are excited to embark on a transformative journey with B-Temia,” said Jason Chen, Chairman and CEO of DIH. “This partnership not only enriches our smart integral solution concept and offers for more transformative effects to our customers, but also will lead to more innovative and close-looped AI & ML-enabled optimizations that may redefine possibilities in rehabilitation.”
“We are excited to join hands with industry Leader DIH in integrating the Keeogo Dermoskeleton product and our AI-based technology into the state-of-the-art DIH platforms sharing the same vision to improve patient outcomes,” said David Quitman, Chief Executive Officer B-Temia.
The partnership between DIH and B-Temia represents a synergy of expertise and innovation, poised to revolutionize the smart robotics solutions for rehabilitation landscape. Together, they are committed to advancing technology-driven solutions that promote independence, mobility, and quality of life for individuals worldwide.
About DIH Holding US, Inc.
DIH stands for the vision to “Deliver Inspiration & Health” to improve the functioning of millions of people with disability and functional impairments. DIH is a global solution provider in blending innovative robotic and virtual reality (“VR”) technologies with clinical integration and insights. Built through the mergers of global-leading niche technologies providers, DIH is positioning itself as a transformative total smart solutions provider and consolidator in a largely fragmented and manual-labor-driven industry.
DIH website: www.DIH.com
About B-Temia Inc.
B-Temia, a strategic partner of Wistron Medical Technology, is at the forefront of human mobility enhancement, specializing in the innovative field of Dermoskeletics™. B-Temia is committed to transforming the way people move through advanced technology that seamlessly integrates with human biomechanics. B-Temia leads in developing groundbreaking mobility solutions that enhance rehabilitation and improve users' quality of life, setting new standards in human performance augmentation.
B-Temia website: www.b-temia.com
For media inquiries, please contact marketing@dih.com
Investor Contact:
Greg Chodaczek
Gilmartin Group
Investor.relations@dih.com
FAQ
What is the new partnership announced by DIH Holding?
What technology will DIH and B-Temia integrate?
Which markets will DIH have exclusive rights for Keeogo?
What are the benefits of the DIH and B-Temia partnership?
When will DIH launch the integrated solutions?
